PreludeDx
Andy brings nearly 20 years of broad corporate finance and accounting experience, including nearly 15 years within the medical device industry. Most recently, Andy was Senior Director Finance and Corporate Controller at Lombard Medical, a publicly-traded medical device company. In addition, Andy has held management positions with a number of life science firms, including Fjord Ventures, Alsius Corporation and Cardiac Science.
Andy began his career with KPMG and holds a B.A. in Business Economics with an emphasis in Accounting from the University of California at Santa Barbara.
This person is not in any offices
PreludeDx
PreludeDx delivers actionable tools to manage early stage breast cancer with the DCIS test that enables personalized treatment.